A specialized company in the development and manufacturing of electro-medical devices, providing non-invasive medical solutions for depression treatment, chronic pain relief, musculoskeletal disorders, and aesthetic applications based on Korea's leading magnetic field technologyAspecializedcompanyinthedevelopmentandmanufacturingofelectro-medicaldevices,providingnon-invasivemedicalsolutionsfordepressiontreatment,chronicpainrelief,musculoskeletaldisorders,andaestheticapplicationsbasedonKorea'sleadingmagneticfieldtechnology
Key Products/TechnologiesKeyProducts/Technologies
Transcranial Magnetic Stimulation Therapy (TMS) product line: 'ALTMS', 'BrainStim', and 'SPRY TMS' (FDA 510(k) Clearance obtained) for depression and stroke rehabilitation, including the world's only portable home-use TMS device weighing under 8kg.TranscranialMagneticStimulationTherapy(TMS)productline:'ALTMS','BrainStim',and'SPRYTMS'(FDA510(k)Clearanceobtained)fordepressionandstrokerehabilitation,includingtheworld'sonlyportablehome-useTMSdeviceweighingunder8kg.
Pain Therapy - Electromagnetic Stimulation Therapy (NMS/PMS) product line: 'SALUS-TALENT', 'SALUS-OPTIMUS PRO', 'SALUS-RSWT', 'ZTone' (Europe CE MDR certified), 'emField Pro', 'Talent-Pro' (US FDA approved) for chronic pain and musculoskeletal disorders.PainTherapy-ElectromagneticStimulationTherapy(NMS/PMS)productline:'SALUS-TALENT','SALUS-OPTIMUSPRO','SALUS-RSWT','ZTone'(EuropeCEMDRcertified),'emFieldPro','Talent-Pro'(USFDAapproved)forchronicpainandmusculoskeletaldisorders.
Pain Therapy - Extracorporeal Shockwave Therapy (ESWT) product line: 'SALUS-RSWT' and the new 'Reftone' for extracorporeal shockwave treatment solutions.PainTherapy-ExtracorporealShockwaveTherapy(ESWT)productline:'SALUS-RSWT'andthenew'Reftone'forextracorporealshockwavetreatmentsolutions.
Core Muscle Strengthen Magnetic Stimulation (CSMS) product line: 'ZTone' for muscle strengthening and aesthetic purposes, and 'MUSFIT', Korea's first MRD (Muscle Retaining Device) device, obtaining KFDA approval.CoreMuscleStrengthenMagneticStimulation(CSMS)productline:'ZTone'formusclestrengtheningandaestheticpurposes,and'MUSFIT',Korea'sfirstMRD(MuscleRetainingDevice)device,obtainingKFDAapproval.
Energy Based Devices (EBD) / Aesthetics product line: 'Cleo V1' utilizing High-Intensity Focused Ultrasound (HIFU) technology, 'Cleo 21' based on Radiofrequency (RF) energy, and 'Lifton' for shockwave lifting, offering solutions for skin tightening, regeneration, and body contouring.EnergyBasedDevices(EBD)/Aestheticsproductline:'CleoV1'utilizingHigh-IntensityFocusedUltrasound(HIFU)technology,'Cleo21'basedonRadiofrequency(RF)energy,and'Lifton'forshockwavelifting,offeringsolutionsforskintightening,regeneration,andbodycontouring.
Bio-signal & Monitoring product line: Patient Monitors, Fetal Monitors, and ECG devices for bio-signal monitoring systems [cite: 데이터베이스].Bio-signal&Monitoringproductline:PatientMonitors,FetalMonitors,andECGdevicesforbio-signalmonitoringsystems[cite:데이터베이스].
Navigation System: 'BrainEyes', a medical stereotactic device that uses brain imaging data to precisely identify stimulation areas for Transcranial Magnetic Stimulators (TMS), having obtained medical device manufacturing certification.NavigationSystem:'BrainEyes',amedicalstereotacticdevicethatusesbrainimagingdatatopreciselyidentifystimulationareasforTranscranialMagneticStimulators(TMS),havingobtainedmedicaldevicemanufacturingcertification.
Core Technology: Leading magnetic field technology in Korea, non-invasive stimulation of nerve cells using powerful pulsed magnetic fields, and successful commercialization of rTMS (repetitive Transcranial Magnetic Stimulation) technology.CoreTechnology:LeadingmagneticfieldtechnologyinKorea,non-invasivestimulationofnervecellsusingpowerfulpulsedmagneticfields,andsuccessfulcommercializationofrTMS(repetitiveTranscranialMagneticStimulation)technology.
Core AdvantagesCoreAdvantages
Proprietary Core Magnetic Field Technology: Possessing leading technology in the electro-pharmaceutical field, based on Korea's best magnetic field technology for non-invasive nerve cell stimulation.ProprietaryCoreMagneticFieldTechnology:Possessingleadingtechnologyintheelectro-pharmaceuticalfield,basedonKorea'sbestmagneticfieldtechnologyfornon-invasivenervecellstimulation.
Global Market Leadership and Expansion: A leading position in the domestic market for TMS devices for depression treatment and NMS devices for chronic pain, with product exports to over 40 countries worldwide.GlobalMarketLeadershipandExpansion:AleadingpositioninthedomesticmarketforTMSdevicesfordepressiontreatmentandNMSdevicesforchronicpain,withproductexportstoover40countriesworldwide.
Acquisition of Multiple International Certifications: Holding numerous major global medical device certifications, including US FDA and Europe CE MDR, confirming product safety and efficacy internationally.AcquisitionofMultipleInternationalCertifications:Holdingnumerousmajorglobalmedicaldevicecertifications,includingUSFDAandEuropeCEMDR,confirmingproductsafetyandefficacyinternationally.
Differentiated Product Portfolio and Technological Innovation: Development of the world's only portable home-use TMS device (under 8kg) and the launch of various energy-based aesthetic devices (HIFU, RF, shockwave) to meet market demands.DifferentiatedProductPortfolioandTechnologicalInnovation:Developmentoftheworld'sonlyportablehome-useTMSdevice(under8kg)andthelaunchofvariousenergy-basedaestheticdevices(HIFU,RF,shockwave)tomeetmarketdemands.
Continuous R&D Investment and Technology Portfolio Expansion: A strong R&D capability, evidenced by 61 patents and 29 government projects, with ongoing efforts to expand indications to various diseases such as dementia and Parkinson's disease.ContinuousR&DInvestmentandTechnologyPortfolioExpansion:AstrongR&Dcapability,evidencedby61patentsand29governmentprojects,withongoingeffortstoexpandindicationstovariousdiseasessuchasdementiaandParkinson'sdisease.
Establishment of Global Partnerships: Collaboration with global healthcare companies such as Zimmer MedizinSysteme (Germany), Enraf (Netherlands), and Allergan (AbbVie, USA) for international market entry and distribution network establishment.EstablishmentofGlobalPartnerships:CollaborationwithglobalhealthcarecompaniessuchasZimmerMedizinSysteme(Germany),Enraf(Netherlands),andAllergan(AbbVie,USA)forinternationalmarketentryanddistributionnetworkestablishment.
Diversification into Various Business Areas: Expansion into multiple medical fields including brain rehabilitation, chronic pain treatment, aesthetics, and pediatric cognitive development therapy, enhancing specialization.DiversificationintoVariousBusinessAreas:Expansionintomultiplemedicalfieldsincludingbrainrehabilitation,chronicpaintreatment,aesthetics,andpediatriccognitivedevelopmenttherapy,enhancingspecialization.
Target IndustrieTargetIndustrie
Medical Industry: Application of medical devices for disease treatment and rehabilitation in various clinical fields such as neuropsychiatry, neurology, rehabilitation medicine, orthopedics, obstetrics and gynecology, and ENT.MedicalIndustry:Applicationofmedicaldevicesfordiseasetreatmentandrehabilitationinvariousclinicalfieldssuchasneuropsychiatry,neurology,rehabilitationmedicine,orthopedics,obstetricsandgynecology,andENT.
Healthcare Industry: Providing solutions for chronic pain management, stroke rehabilitation, and the treatment and prevention of intractable brain diseases like depression, dementia, and Parkinson's disease.HealthcareIndustry:Providingsolutionsforchronicpainmanagement,strokerehabilitation,andthetreatmentandpreventionofintractablebraindiseaseslikedepression,dementia,andParkinson'sdisease.
Aesthetic and Medical Aesthetics Industry: Supplying equipment for cosmetic procedures such as skin tightening, skin regeneration, body contouring, and lifting.AestheticandMedicalAestheticsIndustry:Supplyingequipmentforcosmeticproceduressuchasskintightening,skinregeneration,bodycontouring,andlifting.
Wellness Industry: Offering non-invasive treatment solutions to wellness platforms like Medispa, driven by increasing demand for preventive and health management.WellnessIndustry:Offeringnon-invasivetreatmentsolutionstowellnessplatformslikeMedispa,drivenbyincreasingdemandforpreventiveandhealthmanagement.
All of Europe (CE MDR certified countries), FranceAllofEurope(CEMDRcertifiedcountries),France
United StatesUnitedStates
AustraliaAustralia
South America (including Brazil)SouthAmerica(includingBrazil)
Certifications/PatentsCertifications/Patents
Possession of 61 domestic and international patents, ensuring technological competitiveness.Possessionof61domesticandinternationalpatents,ensuringtechnologicalcompetitiveness.
US FDA Approvals: For TMS 'ALTMS' for depression treatment, NMS 'Talent-Pro' for chronic pain treatment, pain medical device 'COMPACT-II', and Transcranial Magnetic Stimulator 'SPRY TMS', demonstrating recognized safety and efficacy for multiple products.USFDAApprovals:ForTMS'ALTMS'fordepressiontreatment,NMS'Talent-Pro'forchronicpaintreatment,painmedicaldevice'COMPACT-II',andTranscranialMagneticStimulator'SPRYTMS',demonstratingrecognizedsafetyandefficacyformultipleproducts.
Europe CE MDR Certification: For NMS 'ZTone' for chronic pain treatment and overall product compliance with European Medical Device Regulations.EuropeCEMDRCertification:ForNMS'ZTone'forchronicpaintreatmentandoverallproductcompliancewithEuropeanMedicalDeviceRegulations.
Japan Ministry of Health, Labour and Welfare Approval: Obtained approval for 'Talent-Pro' product entry into the Japanese market.JapanMinistryofHealth,LabourandWelfareApproval:Obtainedapprovalfor'Talent-Pro'productentryintotheJapanesemarket.
GMP (Good Manufacturing Practice) Certification: Conformance of the Daejeon headquarters factory to medical device manufacturing and quality management standards.GMP(GoodManufacturingPractice)Certification:ConformanceoftheDaejeonheadquartersfactorytomedicaldevicemanufacturingandqualitymanagementstandards.
Selection as a Next-Generation World-Class Product in 2015: Recognition of the magnetic stimulator product's technological superiority and marketability.SelectionasaNext-GenerationWorld-ClassProductin2015:Recognitionofthemagneticstimulatorproduct'stechnologicalsuperiorityandmarketability.
Government and Institutional Awards: Selected as a Global Hidden Champion in 2020, awarded the Million Dollar Export Tower in 2021, designated as a Technology Innovation Small and Medium Enterprise (Inno-Biz) in 2023, and recognized as an Innovative Medical Device Company in 2024, among other continuous achievements.GovernmentandInstitutionalAwards:SelectedasaGlobalHiddenChampionin2020,awardedtheMillionDollarExportTowerin2021,designatedasaTechnologyInnovationSmallandMediumEnterprise(Inno-Biz)in2023,andrecognizedasanInnovativeMedicalDeviceCompanyin2024,amongothercontinuousachievements.
KFDA approval for 'MUSFIT', Korea's first MRD device, and medical device manufacturing certification for 'BrainEyes', a medical stereotactic device.KFDAapprovalfor'MUSFIT',Korea'sfirstMRDdevice,andmedicaldevicemanufacturingcertificationfor'BrainEyes',amedicalstereotacticdevice.